Technologies that can modulate brain activity raise new ethical questions. Critically examine.

The 2026 Nobel Prize in Physiology or Medicine honoured optogenetics. The technique turns an algal protein into a light-controlled switch for nerve cells, which lets researchers see how neurons shape memories, feelings and behaviour [1]. Older tools could only read the brain, but these tools can write to it. The ethical questions this raises are new in degree, though not all of them are new in kind.

Why the ethical questions are genuinely new

• Mental integrity and autonomy: switching chosen neurons on or off can change mood, memory or behaviour [1]. Consent becomes harder when the tool can alter the mind that is giving the consent.
• Mental privacy: neural data can reveal thoughts, emotions and reactions, and it may be shared without consent [2].
• Commercial misuse: UNESCO warns of workplace productivity tracking, behavioural influence and addiction promotion [2].
• Vulnerable groups: children's brains are still developing, so UNESCO calls for a ban on non-therapeutic neurotechnology for them [2].
• State coercion: in Selvi v. State of Karnataka (2010), the Supreme Court held that compulsory narco-analysis, polygraph and BEAP tests violate Articles 20(3) and 21. It called them an unjustified intrusion into mental privacy [3]. Tools that can change brain activity, not just read it, would make this threat sharper.

Why the concerns should not be overstated

• Therapeutic promise: mapping the circuits behind memory and emotion [1] is the basis for research into neurological and psychiatric disorders. Holding this back would itself be an ethical cost.
• Not wholly unprecedented: ECT and psychosurgery already modulate the brain. The Mental Healthcare Act, 2017 bans ECT without anaesthesia and muscle relaxants. It allows psychosurgery only with informed consent and Board approval [4]. This consent framework can be adapted to new tools.
• Technical barriers: optogenetics only works after a light-sensitive protein has been genetically introduced into target neurons [1]. For now, large-scale misuse is unlikely.
• Norms are emerging: UNESCO adopted the first global standard on neurotechnology ethics in November 2025 [2]. However, it is non-binding and depends on national laws [2].

Brain-modulating technologies raise new ethical questions because they act directly on the mind, but these questions can be governed. India should turn the UNESCO Recommendation into domestic law and treat neural data as sensitive. It should also apply the MHCA's consent safeguards and the Selvi mental-privacy principle to neurotechnology. That way, the right to dignity under Article 21 and SDG-3 health goals are advanced, not traded away.